Artificial Intelligence In Ultrasound Imaging Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Artificial Intelligence In Ultrasound Imaging Market Trends and Insights

Rise in Chronic Diseases & Aging Population

Cardiovascular conditions remain the leading global cause of mortality, while diabetes prevalence is climbing in developing economies ^{[1]World Health Organization, “Cardiovascular Diseases (CVDs),” who.int}. These demographics create permanent demand for imaging that can be performed outside tertiary centers. AI-guided ultrasound lets non-specialists conduct diagnostic-grade scans, multiplying capacity without a proportional increase in radiologists. Chronic-disease pathways benefit because longitudinal monitoring becomes feasible at the bedside, improving adherence to value-based-care metrics and generating recurring software revenue for vendors.

Radiologist Workload Pressures & Staffing Shortages

Imaging volumes outstrip workforce growth. The American College of Radiology cites persistent staffing gaps across rural and urban hospitals ^{[2]American College of Radiology, “Imaging Workforce Trends,” acr.org}. Sonographers are retiring at 60.8 years on average, earlier than the general labor forc. AI reduces interpretation time by automating measurements and triaging normal studies, freeing experts for complex tasks. Emergency departments benefit first, where delays directly affect outcomes.

Government Incentives & Funding for AI Health Tech

The U.S. Department of Health and Human Services 2025 Strategic Plan prioritizes democratizing AI tools across underserved region. China, India, and South Korea have earmarked multi-year grants for ultrasound AI to bolster maternal and cardiac programs. Europe’s AI Act provides predictable approval pathways, encouraging cross-border commercialization ^{[3]European Commission, “Proposal for a Regulation Laying Down Harmonised Rules on AI,” eur-lex.europa.eu}. Grants often bundle staff training, smoothing implementation.

Rapid POCUS Adoption with Integrated AI

WONCA Europe endorses POCUS as a first-line diagnostic tool when augmented by AI guidance; clinicians report higher confidence and patient acceptability. Portable scanners save 21% versus legacy imaging workflows, and AI further trims operator training timelines. Portability unlocks home health, ambulance, and remote-clinic use cases, widening the AI in ultrasound imaging market.

High Procurement & Maintenance Costs

Budget constraints remain the top adoption barrier, particularly for independent clinics. Department heads cite funding gaps despite proven efficacy. Total cost of ownership spans cloud compute fees, license renewals, and staff training. Nonetheless, cross-modality platforms show 451% five-year ROI once scaled across CT, MRI, and ultrasound, and vendors now offer subscription or outcome-linked pricing to soften upfront hits.

Mounting Data-Privacy and Cybersecurity Concerns

FDA bulletins have flagged exploitable vulnerabilities in connected ultrasound gear. HIPAA compliance grows tougher when images transit multiple jurisdictions, demanding sophisticated governance. Privacy-preserving analytics—homomorphic encryption and federated learning—are emerging but add complexity. Procurement teams now mandate robust security audits before signing AI contracts.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Solution: Software Dominance Drives Innovation

Software accounted for 54.67% of the AI in ultrasound imaging market share in 2025. Vendors focus on interoperable algorithms that sit on legacy probes, minimizing capital expenditure. The services line, growing at 33.18% CAGR, reflects rising demand for workflow integration, user training, and algorithm-performance optimization. Health systems seek proof that deployment improves throughput and revenue capture, shifting negotiations toward outcome-based contracts. Meanwhile, hardware makers embed on-device AI accelerators to reduce latency, yet buyers still gravitate to software-first stacks that remain brand-agnostic.

Over the forecast horizon, the AI in ultrasound imaging market will see layered platform ecosystems. Market leaders have opened software development kits that let third parties release specialty plug-ins. Butterfly Network’s Garden AI program exemplifies this move, encouraging cardiovascular, obstetric, and liver-disease modules on a single handheld chassis. Services revenue rises in parallel because each algorithm iteration requires continuous validation, reporting, and clinician retraining.

By Technology: Machine Learning Leads, Context-Aware Computing Surges

Machine-learning models held 42.74% revenue in 2025 thanks to proven gains in automated ejection-fraction measurement and nodule detection. Context-aware computing, projected to grow 33.05% CAGR, builds on this foundation by interpreting ambient data such as patient vitals and provider workflow, then tailoring real-time cues. Natural-language processing adds dictation and auto-reporting, reducing paperwork load, while advanced computer vision handles 3-D reconstructions in labor-intensive specialties.

Context-aware engines resonate strongly in emergency rooms where triage speed is critical. AI cues adapt to trauma protocols, highlighting free fluid in the abdomen during FAST exams. Such specificity pushes adoption deeper into critical-care pathways and expands the overall AI in ultrasound imaging market. Vendors combining multiple modalities—vision, NLP, and signal processing—create high switching costs, an essential moat as more entrants crowd the space.

By Device Type: Handheld Dominance, Wearable Innovation

Handheld probes contributed 35.22% revenue in 2025 as clinicians valued flexibility and lower price points. Enhanced with semiconductor-on-chip designs, new robes function for eight hours on a single charge, supporting rural rounds. Wearables, forecast to grow 33.29% CAGR, turn ultrasound into a continuous-monitoring modality. MIT researchers recently demonstrated a patch that performs automated breast exams, potentially shifting screening into the home.

Hospitals still rely on cart systems for high-resolution studies; however, hybrid laptop units are cannibalizing mid-range carts as departments standardize on multipurpose fleets. Vendors now position wearables as adjuncts rather than replacements, enabling nocturnal cardiac or renal monitoring without nursing intervention. As reimbursement structures adapt, continuous acquisition could redefine how the AI in ultrasound imaging market size is measured, shifting from capital sales to subscription analytics.

By Imaging Mode: 2-D Foundation, Volumetric Growth

2-D mode retained 36.58% share in 2025 because automation of diameter measurements and grayscale categorization yields immediate efficiency. The volumetric segment, with a 33.64% CAGR outlook, benefits from AI that aligns, reconstructs, and color-codes voxels in real time. Siemens Healthineers’ real-time 3-D shear-wave package has cut liver-fibrosis exam times by 48% during pilot programs.

Color-flow Doppler and elastography also accelerate, powered by AI that suppresses artefacts and quantifies stiffness more reliably than manual techniques. Contrast-enhanced ultrasound gains traction as algorithms predict optimum bolus timing, maximizing diagnostic yield without escalating dose. The AI in ultrasound imaging market thus shifts toward higher-complexity modes once thought niche, broadening the value proposition beyond routine scans.

By Application: Cardiology Leadership, Obstetrics Acceleration

Cardiology commanded 39.66% of the 2025 revenue base. Automated strain analysis and quantification of diastolic function underpin clear clinical utility in heart-failure management. Obstetrics and gynecology, set for 33.12% CAGR, relies on AI to flag structural anomalies and monitor growth curves. Samsung Medison’s newly integrated Sonio algorithms detect 165 fetal malformations and generate instant reports, trimming scan duration by 30%.

Gastroenterology sees momentum as AI improves liver steatosis scoring, while musculoskeletal practices adopt guided needle-placement tools. Oncology teams employ AI for tumor volumetry, feeding response data straight into treatment-planning systems. As subspecialty modules proliferate, the AI in ultrasound imaging market turns into a mosaic of micro-workflows, each contributing incremental volume and reinforcing platform stickiness.

By End User: Hospital Dominance, Ambulatory Expansion

Hospitals delivered 58.12% of revenue in 2025, leveraging enterprise PACS and analytics dashboards. Ambulatory clinics and urgent-care chains will post 33.48% CAGR because handheld AI probes let primary-care physicians rule out serious pathology on the spot. The University of Rochester Medical Center rolled out 862 devices across internal medicine, cardiology, and emergency services, boosting charge capture 116% in the first year.

Diagnostic imaging centers integrate AI to standardize reports across multi-site franchises, while home-care agencies pilot remote sonography with cloud-linked AI supervision. As aging populations prefer in-home services, payer policies continue to evolve, further enlarging the AI in ultrasound imaging market size for community-centric providers.

Geography Analysis

North America retained 47.62% share in 2025, bolstered by CMS reimbursement for AI echocardiography and a streamlined FDA approval framework. Leading health systems bundle AI ultrasound into cardiovascular centers of excellence, emphasizing outcome-based purchasing. Venture capital flows remain strong, but workforce shortages sustain the need for automation, thereby reinforcing future capital spending.

Asia-Pacific is the fastest-growing block with a 33.74% CAGR outlook. China’s Healthy China 2030 plan and India’s Ayushman Bharat initiative earmark funds for maternal-fetal diagnostics, while South Korea offers R&D tax credits for local AI developers. Cross-border partnerships, such as UltraSight’s alliance with SELVAS Healthcare to distribute cardiac AI throughout Southeast Asia, exemplify go-to-market tactics that marry international algorithms with local channel expertise.

Europe pursues measured expansion rooted in ethical governance. The AI Act’s risk-classification scheme compels vendors to document datasets and bias-mitigation efforts, but it also gives health systems confidence to procure at scale. Germany and the Nordic countries champion national ultrasound registries that feed back into AI model retraining, forming a virtuous cycle of quality assurance. Collectively, these trends consolidate the AI in ultrasound imaging market across advanced and emerging economies alike.

Regulatory Landscape

Regulation for AI-enabled ultrasound covers device approvals, lifecycle change management, and data governance. In the United States, the FDA has moved toward clearer pathways for iterative model updates through Predetermined Change Control Plans (PCCPs), including final PCCP guidance issued on December 3, 2024 and follow-on implementation recommendations released on August 18, 2025. On June 17, 2026, the FDA classified radiological machine learning-based quantitative imaging software with PCCP into Class II under 21 CFR 892.2055, reinforcing a scalable route for software updates without repeated premarket submissions when changes stay within an approved plan.

In Europe, obligations are tightening alongside harmonized AI governance. Draft provisions released by the European Commission on June 1, 2026 included a proposal that portable ultrasound devices sold in the EU from January 2027 and classified Class IIa and above must include CE-certified AI-assisted diagnostic modules, raising the compliance bar for handheld and point-of-care platforms. In Asia, China’s NMPA has published multiple technical review guides for AI-enabled medical devices in radiology and imaging by 2025, including expectations around patient-data de-identification, which affects cross-border dataset strategy and postmarket monitoring design.

Value Chain Analysis

The value chain for AI in ultrasound imaging connects ultrasound OEMs (cart, compact, handheld, and emerging wearable platforms), transducer and semiconductor supply, AI model development and validation, regulatory and quality management, and systems integration (PACS, EHR, reporting). Clinical deployment then feeds into ongoing performance management, including monitoring, updates, cybersecurity, and user training. Major device manufacturers such as GE HealthCare, Siemens Healthineers, and Samsung Medison increasingly position themselves as orchestrators of a full-stack workflow that bundles acquisition, AI-assisted guidance and quantification, and reporting, while specialized software developers contribute niche algorithms that expand applications across cardiology, OB-GYN, and other specialties.

Ecosystem consolidation and platformization are also changing how value is captured across the chain. A representative move is Samsung Medison’s May 2024 acquisition of French AI ultrasound startup Sonio (USD 92.7 million), which brought algorithm capability closer to the OEM layer and supports tighter integration with installed hardware fleets. At the same time, stakeholders are operationalizing Good Machine Learning Practice (GMLP) and adaptive software architectures supported by PCCP-style frameworks, shifting competition toward continuous validation, update governance, and multi-vendor generalization rather than one-off algorithm releases.

Market Opportunities and Future Outlook

A key whitespace remains in scaling AI-guided acquisition beyond expert sonographers, particularly for point-of-care and resource-limited environments where access and training are still binding constraints. Evidence from clinical evaluations cited in recent literature indicates that AI-assisted acquisition platforms can guide novice users and reduce time to diagnosis in non-inferiority settings, supporting use cases where standardized scans are needed without extensive operator experience. Vendors can therefore package onboarding, workflow integration, and ongoing monitoring services alongside software licenses, especially as health systems standardize deployments across departments and sites.

Clinical research and enterprise workflow automation also offer a monetization pathway, since automated ultrasound quantification can support consistent endpoints for multi-site trials and reduce dependence on centralized expert readers in cardiac and pulmonary studies. Regulatory mechanisms that formalize controlled model updates, such as the FDA’s PCCP framework and the June 2026 Class II classification for radiological ML quantitative imaging software with PCCP, allow more frequent algorithm iteration under defined change plans. In parallel, EU draft provisions published in June 2026 that propose AI module requirements for certain portable ultrasound devices from January 2027 lift demand for compliant, CE-ready AI packages, which is pushing vendors to invest in traceable datasets, bias mitigation documentation, and cybersecurity-by-design as commercial differentiators.